Nat West Group PLC Medtronic PLC Transaction History

Nat West Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$100.57 - $117.14 $590,044 - $687,260	-5,867 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$90.13 - $108.78 $54,078 - $65,268	-600 Reduced 9.28%	5,867 $610,000
Q2 2020 Jul 16, 2020	SELL	$84.11 - $103.33 $168,220 - $206,660	-2,000 Reduced 23.62%	6,467 $593,000
Q4 2019 Feb 06, 2020	BUY	$104.49 - $114.54 $884,716 - $969,810	8,467 New	8,467 $961,000

2,222

1.04B

7.09M

4.39M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $117B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Nat West Group PLC, based on Form 13F filings with the SEC.

Stay updated on Nat West Group PLC with notifications on news.